 |
Drug Delivery and Formulation America Summit 2012
April 30, 2012—May 1, 2012
San Diego, California
PEGS Summit 2012
April 30, 2012—May 1, 2012
Boston, Massachusetts
Pharmaceutical Cold Chain Compliance
April 30, 2012—May 2, 2012
Philadelphia, Pennsylvania
INTERPHEX 2012
May 1, 2012—May 3, 2012
New York, New York
CPhI South East Asia
May 10, 2012—May 12, 2012
Jakarta, Indonesia 
|
|
|
 |
 |
AstraZeneca has agreed to acquire Ardea Biosciences, a biotechnology company focused on the development of small-molecule therapeutics for $1.26 billion. The acquisition will include Ardea's product candidate lesinurad (formerly known as RDEA594), a selective inhibitor of URAT1 that is currently in Phase III development as a potential treatment for the chronic management of hyperuricaemia in patients with gout. Read More
Advertisement:
Handheld Raman Accelerates Raw Material Release
Enwave Optronics introduces the NEW ASSU℞ Handheld Raman Analyzer for raw material verification. Most materials are measured and evaluated within 15 seconds. The ASSU℞ is fully 21 CFR Part 11 compliant for GMP requirements. It is an ideal choice for pharmaceutical, industrial chemicals and applications requiring high speed, reliable Raman analysis.
Enwave Optronics, Inc.
 http://www.enwaveopt.com/EZRaman-H.htm
|
Human Genome Sciences (HGS) has rejected an unsolicited proposal from GlaxoSmithKline (GSK) to acquire HGS for $13.00 per share in cash ($2.59 billion total). HGS's board of directors has authorized the exploration of strategic alternatives in the best interests of shareholders, including, but not limited to, a potential sale of the company. GSK has been invited to participate in this process and HGS has requested additional information regarding investigational products in GSK's clinical pipeline to which HGS has substantial financial rights, including darapladib, in Phase II development for treating cardiovascular disease, and albiglutide, in Phase III development for treating Type II diabetes. Read More
Advertisement:
Single Use Molded Manifold Connections – Complimentary Sample
Single use manifolds combine tubing with molded fittings to eliminate many barbed fitting connections and their risk for leaks and contamination. Manufactured in the U.S. from platinum-cured silicone or AdvantaFlex® biopharmaceutical TPE. Validation and extractables test portfolios available, as well as validated sterility assurance. Request a connection sample or see it at Interphex booth 3055.
AdvantaPure®
 http://www.advantapure.com/sample-pt3 |
Pfizer has agreed to divest its nutrition business to Nestlé for $11.85 billion in cash. Pfizer's nutrition business recorded revenues of approximately $2.1 billion in 2011, an increase of 15% versus 2010. The transaction is subject to customary closing conditions, including the receipt of regulatory approvals in certain jurisdictions. Upon completion of the transaction, Pfizer's nutrition employees will be transferred to Nestlé, subject to works council and union consultation where required. Read More
Advertisement:
Podcast -  Process Validation for Sterile Manufacturing
Join William (JR) Humbert, the Validation Manager at Cook Pharmica, as he discusses the 2011 FDA Guidance for the Industry, Process Validation: General Principles and Practices, and the impact the guidance has for biotechnology and pharmaceutical companies performing sterile manufacturing process validation. |
Industry Briefs:
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers. Read More
Advertisement:
Meeting New Method Transfer Requirements
Live Webcast: May 15, 2012 at 11:00 AM EDT for North America and May 22, 2012 at 11:00 AM CET for Europe
Register Free at  http://www.pharmtech.com/method. |
Do you have news to report on facility expansions, contracts, service agreements, mergers, acquisitions, or personnel appointments? Send press releases to [email protected] |
Advertisement:
21 CFR Part 11 Compliance and Business Benefits of Digital Signatures
Event Date: May 09, 2012 at 11:00 AM Eastern Daylight Time
Register for this FREE Webcast at www.pharmtech.com/signature |
|
|
 |
| Freeze-Drying: Is Technology Advancing Fast Enough? |
by: Stephanie Sutton
Experts discuss the best practices for developing a QbD-based lyophilization process.
 |
Coming soon: Don't miss the results of our annual bioprocessing survey in the supplement to Pharm Tech's May issue. |
|
|
|
Know Before You Go—2012 Conference Previews
Visit our Show & Exhibition Gateway 2012 to see which companies are exhibiting at upcoming industry conferences.
Find company backgrounders, new product releases, booth materials, and more. Let PharmTech's online
Gateway be your guide to the season's leading shows.
|
|
|
|
|
|
Industrial vision system inspects parts at high speeds
